Homegrown healthtech startup 4baseCare has secured $6 million (around Rs 50 crore) in its Series A funding round led by Yali Capital.
The round also saw participation from other investors as well.
The startup plans to use the fresh investment for ramping up its product offerings focused on building genomics and digital health solutions as well as planning global expansion, targeting the Asian and Middle East markets.
“The success of our test and our growth over the years is a result of the exceptional support from our investors and the invaluable insights from our advisory board. This funding will further enable us to enhance our product offerings and advance our mission of making personalised cancer care accessible to millions,” said Hitesh Goswami, CEO and Co-founder, 4baseCare.
Moreover, the Bengaluru-based startup also plans to establish genomics laboratories in the Philippines, Nepal, and Dubai over the coming months.
“As a deep tech focused fund, we are particularly excited about 4baseCare’s ability to enhance genomic tests with data from underrepresented populations, leading to improved treatment recommendations. 4baseCare has demonstrated impressive growth over the last few years, and we look forward to helping the team build a sustainable and profitable business,” Mathew Cyriac, Founding General Partner, Yali Capital, said.
The startup was founded in 2018 by Goswami and Kshitij Rishi. It specialises in precision oncology through advanced genomics and digital health technologies.
4baseCare’s genomic tests have made a substantial impact across SouthEast Asia, benefiting more than 10,000 cancer patients.